| Literature DB >> 27076351 |
Angelica Van Goor1, Christopher M Ashwell2, Michael E Persia3, Max F Rothschild1, Carl J Schmidt4, Susan J Lamont5.
Abstract
BACKGROUND: Heat stress in poultry results in considerable economic losses and is a concern for both animal health and welfare. Physiological changes occur during periods of heat stress, including changes in blood chemistry components. A highly advanced intercross line, created from a broiler (heat susceptible) by Fayoumi (heat resistant) cross, was exposed to daily heat cycles for seven days starting at 22 days of age. Blood components measured pre-heat treatment and on the seventh day of heat treatment included pH, pCO2, pO2, base excess, HCO3, TCO2, K, Na, ionized Ca, hematocrit, hemoglobin, sO2, and glucose. A genome-wide association study (GWAS) for these traits and their calculated changes was conducted to identify quantitative trait loci (QTL) using a 600 K SNP panel.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27076351 PMCID: PMC4831167 DOI: 10.1186/s12864-016-2601-x
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Phenotypic means and heritabilities (h2)
| Trait | Day 20 | Day 28 | Day 28-20 | |||
|---|---|---|---|---|---|---|
| Mean ± SEM | h2 (SE) | Mean ± SEM | h2 (SE) | Mean ± SEM | h2 (SE) | |
| pH | 7.50 ± 0.0a | .17 (0.08) | 7.53 ± 0.003b | .10 (0.08) | 0.03 ± 0.004 | .05 (0.03) |
| pCO2, mmHg | 31.9 ± 0.1a | .21 (0.06) | 31.1 ± 0.2b | .05 (0.04) | −0.8 ± 0.2 | .07 (0.05) |
| pO2, mmHg | 43.3 ± 0.3a | .06 (0.04) | 43.9 ± 0.2a | .05 (0.05) | 0.5 ± 0.3 | .00 (0.03) |
| BE, mM | 1.8 ± 0.1a | .10 (0.05) | 3.3 ± 0.2b | .02 (0.02) | 1.5 ± 0.2 | .00 (0.02) |
| HCO3, mM | 25.0 ± 0.1a | .05 (0.04) | 26.0 ± 0.1b | .23 (0.12) | 1.0 ± 0.2 | .03 (0.02) |
| TCO2, mM | 25.9 ± 0.1a | .02 (0.03) | 26.9 ± 0.1b | .13 (0.09) | 1.0 ± 0.2 | .01 (0.01) |
| K, mM | 4.8 ± 0.0a | .20 (0.01) | 4.9 ± 0.0a | .02 (0.01) | 0.1 ± 0.0 | .10 (0.06) |
| Na, mM | 137.0 ± 0.2a | .08 (0.6) | 137.2 ± 0.3a | .01 (0.01) | 0.3 ± 0.3 | .01 (0.01) |
| iCa, mM | 1.25 ± 0.0a | .04 (0.01) | 1.28 ± 0.01b | .02 (0.01) | 0.02 ± 0.01 | .01 (0.01) |
| Hct, % PCV | 22.5 ± 0.2a | .01 (0.03) | 23.2 ± 0.1b | .21 (0.08) | 0.7 ± 0.2 | .02 (0.01) |
| Hb, g/dL | 7.7 ± 0.1a | .07 (0.05) | 7.9 ± 0.0b | .11 (0.04) | 0.2 ± 0.1 | .02 (0.01) |
| sO2, % | 83.2 ± 0.2a | .03 (0.05) | 84.7 ± 0.2b | .02 (0.02) | 1.5 ± 0.3 | .01 (0.01) |
| Glu, mg/dl | 252 ± 0.8a | .15 (0.08) | 243 ± 1b | .19 (0.09) | −8 ± 1 | .02 (0.02) |
Blood chemistry components were measured pre-heat (day 20), on the seventh day of heat treatment (day 28), and the calculated change due to heat (day 28–20). Different superscript letters within row represent significant differences (P ≤ 0.05)
Fig. 1Heat map of phenotypic correlations between blood chemistry components. Heat map showing phenotypic correlations between blood chemistry components measured on day 20 (pre-heat), day 28 (during heat), and day 28–20 which is the difference due to heat treatment. Traits are clustered together based on function. The colors represent the correlation coefficient (r2) with red indicating a positive correlation and blue indicating a negative correlation
Fig. 2Genome-wide plot of percentage of genetic variance for traits measured during heat stress. Traits were measured before heat treatment (day 20) and during heat treatment (day 28), and the differentials were also calculated (day 28-20). The traits that reached significance in the GWAS (≥0.05 % of the genetic variation) are displayed. Results show the percentage of genetic variance that is explained by each non-overlapping 1-Mb window, labeled by the index number of the windows, and are colored and ordered by chromosome (1 to 28, and Z). Plots display: pH on days 20 and 28, and the differential 28–20 (a, b, and c); partial CO2 (pCO2) on days 20, 28, and the differential 28–20 (d, e, and f); partial O2 (pO2) on day 28, (g); base excess on day 20 and day 28, (h and i); bicarbonate (HCO3) on day 28 (j); total CO2 (TCO2) on day 28 and the differential 28–20 (k and l); potassium (K) on days 20 and the differential 28–20 (m and n); ionized calcium (iCa) on day 28 (o); hematocrit (Hct) on day 28 (p); hemoglobin (Hb) on day 28 and the differential 28–20 (q and r); saturated oxygen (SO2) on day 28 and the differential (s and t); glucose on days 20 and 28 (u and v)
Windows explaining a significant percentage (≥0.5) of genetic variance
| Windows explaining ≥ 0.5 % of genetic variance | SNP with highest model frequency within window | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Traita | Chr | Pos (Mb) | % of genetic variance explained | Nb of SNPs | Freq of iterations with ( | SNP namec | SNP pos (bp)d | Model freqe | Allele freqf |
| pH20 | 18 | 3 | 1.29 | 401 | 0.94 | AX-75894740 | 3342614 | 0.0111 | 0.652 |
| pH20 | 28 | 4 | 1.01 | 328 | 0.85 | AX-76384843 | 4097788 | 0.0090 | 0.294 |
| pH20 | 28 | 3 | 0.64 | 437 | 0.92 | AX-76383580 | 3856132 | 0.0092 | 0.294 |
| pH20 | 18 | 6 | 0.58 | 342 | 0.86 | AX-75894671 | 6670745 | 0.0075 | 0.340 |
| pH28 | 12 | 7 | 0.55 | 302 | 0.81 | AX-75723368 | 7630857 | 0.0070 | 0.288 |
| pH28-20 | 6 | 4 | 0.66 | 350 | 0.86 | AX-76958371 | 4259110 | 0.0074 | 0.724 |
| pH28-20 | 10 | 16 | 0.50 | 372 | 0.89 | AX-75591175 | 16460945 | 0.0066 | 0.298 |
| pCO220 | 28 | 3 | 9.75 | 437 | 0.93 | AX-76383461 | 3835952 | 0.0448 | 0.711 |
| pCO220 | 28 | 4 | 4.49 | 328 | 0.89 | AX-76385219 | 4167579 | 0.0239 | 0.706 |
| pCO228 | 9 | 20 | 0.59 | 462 | 0.94 | AX-75706074 | 19358758 | 0.0070 | 0.416 |
| pCO228 | 1 | 110 | 0.54 | 194 | 0.38 | AX-80866127 | 110487208 | 0.0098 | 0.510 |
| pCO228 | 27 | 2 | 0.53 | 650 | 0.96 | AX-76356017 | 2038872 | 0.0065 | 0.653 |
| pCO228 | 10 | 3 | 0.50 | 447 | 0.91 | AX-75607032 | 3037730 | 0.0069 | 0.626 |
| pCO228-20 | 28 | 4 | 0.61 | 328 | 0.83 | AX-76384843 | 4097788 | 0.0076 | 0.296 |
| pCO228-20 | 23 | 2 | 0.57 | 388 | 0.86 | AX-76282215 | 2594470 | 0.0071 | 0.435 |
| pCO228-20 | 3 | 14 | 0.56 | 287 | 0.81 | AX-76421954 | 14679413 | 0.0075 | 0.323 |
| pCO228-20 | 10 | 1 | 0.50 | 393 | 0.86 | AX-75601081 | 1816619 | 0.0080 | 0.339 |
| pO228 | 13 | 5 | 0.57 | 277 | 0.79 | AX-75758019 | 5130673 | 0.0070 | 0.531 |
| BE20 | 18 | 3 | 0.68 | 401 | 0.93 | AX-75894740 | 3342614 | 0.0103 | 0.652 |
| BE20 | 18 | 6 | 0.52 | 342 | 0.84 | AX-75906711 | 6859485 | 0.0078 | 0.554 |
| BE28 | 27 | 2 | 0.70 | 650 | 0.97 | AX-76359325 | 2733806 | 0.0076 | 0.473 |
| BE28 | 1 | 172 | 0.54 | 202 | 0.67 | AX-75342016 | 172010216 | 0.0094 | 0.683 |
| BE28 | 21 | 4 | 0.50 | 521 | 0.91 | AX-76247040 | 4491122 | 0.0078 | 0.321 |
| HCO328 | Z | 30 | 4.11 | 74 | 0.47 | AX-77209983 | 30284984 | 0.1864 | 0.671 |
| HCO328 | Z | 8 | 3.10 | 24 | 0.27 | AX-80958477 | 8485438 | 0.0719 | 0.357 |
| HCO328 | Z | 5 | 2.22 | 62 | 0.33 | AX-80834191 | 5042699 | 0.0931 | 0.634 |
| HCO328 | Z | 33 | 2.09 | 45 | 0.28 | AX-80973925 | 33940034 | 0.0543 | 0.608 |
| HCO328 | Z | 35 | 1.67 | 128 | 0.50 | AX-80901519 | 35319963 | 0.0589 | 0.379 |
| HCO328 | Z | 7 | 1.47 | 2 | 0.9 | AX-77264084 | 7705768 | 0.0806 | 0.311 |
| HCO328 | Z | 70 | 1.45 | 55 | 0.28 | AX-77257752 | 70210948 | 0.0625 | 0.376 |
| HCO328 | Z | 69 | 1.31 | 113 | 0.40 | AX-80879264 | 69810199 | 0.0525 | 0.370 |
| HCO328 | 6 | 25 | 0.75 | 325 | 0.86 | AX-76932184 | 25826439 | 0.0083 | 0.466 |
| HCO328 | Z | 71 | 0.74 | 183 | 0.62 | AX-80943753 | 71554374 | 0.0520 | 0.360 |
| HCO328 | 6 | 26 | 0.53 | 291 | 0.83 | AX-76933234 | 26203623 | 0.0092 | 0.493 |
| TCO228 | Z | 69 | 3.63 | 113 | 0.46 | AX-80879264 | 69810199 | 0.1357 | 0.370 |
| TCO228 | Z | 30 | 3.04 | 74 | 0.44 | AX-77209983 | 30284984 | 0.1424 | 0.671 |
| TCO228 | Z | 8 | 2.30 | 24 | 0.25 | AX-80958477 | 8485438 | 0.0859 | 0.357 |
| TCO228 | Z | 33 | 1.73 | 45 | 0.28 | AX-80973925 | 33940034 | 0.0667 | 0.608 |
| TCO228 | Z | 5 | 1.60 | 62 | 0.29 | AX-80834191 | 5042699 | 0.0700 | 0.634 |
| TCO228 | Z | 7 | 1.23 | 2 | 0.7 | AX-77264084 | 7705768 | 0.0707 | 0.311 |
| TCO228 | Z | 70 | 0.91 | 55 | 0.26 | AX-77257752 | 70210948 | 0.0434 | 0.376 |
| TCO228 | Z | 35 | 0.80 | 128 | 0.48 | AX-80901519 | 35319963 | 0.0419 | 0.379 |
| TCO228 | 6 | 25 | 0.66 | 325 | 0.85 | AX-76932184 | 25826439 | 0.0080 | 0.466 |
| TCO228 | 26 | 3 | 0.51 | 616 | 0.98 | AX-80958155 | 3785485 | 0.0079 | 0.513 |
| TCO228-20 | 10 | 5 | 0.51 | 515 | 0.93 | AX-75615576 | 5758221 | 0.0067 | 0.355 |
| K20 | 10 | 16 | 0.76 | 372 | 0.92 | AX-75589587 | 16018566 | 0.0041 | 0.249 |
| K20 | 10 | 18 | 0.53 | 496 | 0.96 | AX-75597981 | 18294286 | 0.0038 | 0.278 |
| K20 | 12 | 17 | 0.53 | 242 | 0.72 | AX-75701199 | 17759131 | 0.0043 | 0.646 |
| K20 | 26 | 3 | 0.50 | 616 | 0.96 | AX-76340450 | 3273628 | 0.0036 | 0.180 |
| K28-20 | 12 | 16 | 1.29 | 246 | 0.75 | AX-75696568 | 16220734 | 0.0036 | 0.650 |
| K28-20 | 12 | 17 | 0.69 | 242 | 0.70 | AX-75701149 | 17743731 | 0.0043 | 0.633 |
| iCa28 | 26 | 3 | 0.52 | 616 | 0.96 | AX-76343628 | 3922118 | 0.0076 | 0.550 |
| Hct28 | 14 | 11 | 1.78 | 391 | 0.94 | AX-75776707 | 11791127 | 0.0096 | 0.502 |
| Hct28 | 1 | 169 | 1.17 | 196 | 0.83 | AX-75336362 | 169571235 | 0.0110 | 0.714 |
| Hct28 | 28 | 3 | 1.01 | 437 | 0.92 | AX-76384000 | 3944019 | 0.0116 | 0.397 |
| Hct28 | 28 | 4 | 0.93 | 328 | 0.91 | AX-76385356 | 4197143 | 0.0113 | 0.408 |
| Hct28 | 22 | 3 | 0.88 | 573 | 0.95 | AX-76269662 | 3474970 | 0.0072 | 0.513 |
| Hct28 | 10 | 16 | 0.59 | 372 | 0.90 | AX-75589730 | 16057907 | 0.0070 | 0.254 |
| Hb28 | 14 | 11 | 1.64 | 391 | 0.95 | AX-75776707 | 11791127 | 0.0091 | 0.502 |
| Hb28 | 1 | 169 | 1.33 | 196 | 0.83 | AX-75337336 | 169979876 | 0.0121 | 0.322 |
| Hb28 | 28 | 3 | 0.96 | 437 | 0.91 | AX-76384000 | 3944019 | 0.0112 | 0.397 |
| Hb28 | 28 | 4 | 0.94 | 328 | 0.92 | AX-76385356 | 4197143 | 0.0103 | 0.408 |
| Hb28 | 22 | 3 | 0.79 | 573 | 0.95 | AX-76269662 | 3474970 | 0.0073 | 0.513 |
| Hb28 | 10 | 16 | 0.60 | 372 | 0.90 | AX-75590148 | 16177101 | 0.0077 | 0.295 |
| Hb28 | 1 | 170 | 0.50 | 176 | 0.65 | AX-75337520 | 170074107 | 0.0083 | 0.676 |
| Hb28-20 | 22 | 3 | 1.71 | 573 | 0.96 | AX-76272400 | 3857927 | 0.0072 | 0.533 |
| sO228 | 25 | 0 | 1.23 | 364 | 0.91 | AX-75758019 | 5130673 | 0.0070 | 0.531 |
| sO228 | 24 | 3 | 0.55 | 581 | 0.94 | AX-76328225 | 36480 | 0.0111 | 0.618 |
| sO228-20 | 17 | 6 | 0.53 | 324 | 0.83 | AX-75872796 | 6506736 | 0.0066 | 0.412 |
| sO228-20 | 17 | 7 | 0.53 | 467 | 0.88 | AX-75875111 | 7125729 | 0.0066 | 0.172 |
| Glu20 | 10 | 4 | 0.67 | 548 | 0.95 | AX-80975590 | 4452892 | 0.0067 | 0.740 |
| Glu28 | 22 | 3 | 1.09 | 573 | 0.94 | AX-76273189 | 3966852 | 0.0070 | 0.585 |
| Glu28 | Z | 5 | 0.79 | 62 | 0.28 | AX-80834191 | 5042699 | 0.0246 | 0.634 |
| Glu28 | Z | 70 | 0.74 | 55 | 0.24 | AX-77257752 | 70210948 | 0.0266 | 0.376 |
| Glu28 | Z | 69 | 0.64 | 113 | 0.42 | AX-80879264 | 69810199 | 0.0187 | 0.371 |
aBlood chemistry components were measured pre-heat (day 20), on the seventh day of heat treatment (day 28), and the calculated differential due to heat (day 28–20)
bFrequency in which the window was included in the MCMC iterations (post-burn-in)
cSNP within the specified window which was most frequently included in the MCMC iterations (post-burn-in), and is therefore predicted to have the greatest effect on the phenotype
dPosition of SNPs in base pairs on Gallus-gallus (version 4.0) chromosome
eFrequency in which the SNP was included in the MCMC iterations (post-burn-in) model
fAllele frequency of the SNP in the genotyped population (N = 458)
Top 20 canonical pathways for QTL identified for all traits, and for co-localized QTL
| Pathways for all identified QTL | |||
|---|---|---|---|
| Pathway |
| Ratio: | Genes in pathway that were identified in current study |
| 1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian) | 1.93E-03 | 4/19 | INPP5E,IPMK,SEC16A,PMPCA |
| AMPK Signaling | 2.15E-03 | 13/178 | CHRNA5,MTOR,STRADA,AK8,INSR,CHRNA3,PPM1J,CHRNB4,PIK3R2,ADRA2A,TSC1,FOXO1,ADRA1A |
| Angiopoietin Signaling | 1.22E-03 | 6/66 | NRAS,PIK3R2,BIRC5,CASP9,IKBKAP,FOXO1 |
| Calcium Signaling | 1.51E-02 | 11/178 | CALR,CHRNA5,MYL4,CHRNB4,CAMK4,CHRNA3,CAMK1G,MEF2D,TPM1,RAP1A,MEF2A |
| Cardiac Hypertrophy Signaling | 5.80E-03 | 14/223 | MTOR,MYL4,CAMK4,RHOC,IGF1R,NRAS,PIK3R2,RHOT1,ADRA2A,MEF2D,MAP3K3,CACNA1D,MEF2A,ADRA1A |
| D-myo-inositol (1,3,4)-trisphosphate Biosynthesis | 1.93E-03 | 4/19 | INPP5E,IPMK,SEC16A,PMPCA |
| D-myo-inositol (1,4,5)-trisphosphate Degradation | 1.44E-02 | 3/18 | INPP5E,SEC16A,PMPCA |
| Dopamine Degradation | 8.29E-03 | 4/28 | ALDH1A1,ALDH1A3,MAOB,ALDH4A1 |
| ERK5 Signaling | 2.28E-03 | 7/63 | MAP2K5,NRAS,NTRK1,MEF2D,NGF,MAP3K3,MEF2A |
| Ethanol Degradation IV | 4.02E-03 | 4/23 | ALDH1A1,TYRP1,ALDH1A3,ALDH4A1 |
| Glioblastoma Multiforme Signaling | 1.03E-02 | 10/146 | WNT2B,IGF1R,NRAS,MTOR,PIK3R2,WNT5A,RHOC,RHOT1,TSC1, FOXO1 |
| Glioma Signaling | 7.71E-03 | 8/98 | ABL1,TGFA,IGF1R,NRAS,MTOR,PIK3R2,CAMK4,CAMK1G |
| Histamine Degradation | 1.22E-02 | 3/17 | ALDH1A1,ALDH1A3,ALDH4A1 |
| Human Embryonic Stem Cell Pluripotency | 1.85E-03 | 11/134 | WNT2B,PIK3R2,WNT5A,SMAD3,SMAD6,NTRK1,TCF7L2,BMP2,NGF,FOXO1,NOG |
| Non-Small Cell Lung Cancer Signaling | 1.13E-02 | 6/65 | ABL1,TGFA,NRAS,PIK3R2,CASP9,RXRA |
| Nur77 Signaling in T Lymphocytes | 1.26E-03 | 7/57 | MAP2K5,SIN3B,CASP9,RXRA,CAMK4,MEF2D,MAP3K3 |
| Putrescine Degradation III | 2.84E-03 | 4/21 | ALDH1A1,ALDH1A3,MAOB,ALDH4A1 |
| Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism | 4.71E-03 | 4/24 | INPP5E,IPMK,SEC16A,PMPCA |
| Thyroid Cancer Signaling | 9.69E-04 | 6/40 | NRAS,RET,RXRA,NTRK1,TCF7L2,NGF |
| Tryptophan Degradation X (Mammalian, via Tryptamine) | 4.02E-03 | 4/23 | ALDH1A1,ALDH1A3,MAOB,ALDH4A1 |
| Pathways identified for co-localized QTL | |||
| Pathway |
| Ratio: | Genes in pathway that were identified in current study |
| 2-oxobutanoate Degradation I | 4.22E-02 | 1/5 | MCEE |
| AMPK Signaling | 4.42E-03 | 6/178 | CHRNA5,PPM1J,CHRNB4,INSR,CHRNA3,ADRA1A |
| Calcium Signaling | 1.55E-04 | 8/178 | CALR,CHRNA5,CHRNB4,CHRNA3,CAMK1G,TPM1,RAP1A,MEF2A |
| Cardiac Hypertrophy Signaling | 4.35E-02 | 5/223 | IGF1R,NRAS,RHOC,MEF2A,ADRA1A |
| CDK5 Signaling | 4.94E-02 | 3/105 | NRAS,PPM1J,NGF |
| Cholecystokinin/Gastrin-mediated Signaling | 4.95E-02 | 3/245 | NRAS,RHOC,MEF2A |
| CTLA4 Signaling in Cytotoxic T Lymphocytes | 4.01E-02 | 3/88 | PPM1J,PTPN22,AP1M1 |
| ERK5 Signaling | 1.69E-02 | 3/63 | NRAS,NGF,MEF2A |
| Germ Cell-Sertoli Cell Junction Signaling | 4.93E-02 | 4/160 | NRAS,TJP1,RHOC,RAB8B |
| Glioblastoma Multiforme Signaling | 3.73E-02 | 4/146 | WNT2B,IGF1R,NRAS,RHOC |
| Glioma Signaling | 1.01E-02 | 4/98 | TGFA,IGF1R,NRAS,CAMK1G |
| Integrin Signaling | 3.33E-02 | 5/207 | NRAS,TSPAN2,RHOC,TLN2,RAP1A |
| Methylmalonyl Pathway | 3.39E-02 | 1/4 | MCEE |
| mTOR Signaling | 2.28E-02 | 5/187 | NRAS,PPM1J,INSR,RHOC,RPS15 |
| NF-κB Signaling | 1.65E-02 | 5/172 | TGFA,IGF1R,NRAS,INSR,NGF |
| PTEN Signaling | 1.89E-02 | 4/118 | IGF1R,NRAS,INSR,MAGI3 |
| Renal Cell Carcinoma Signaling | 2.32E-02 | 3/71 | TGFA,NRAS,RAP1A |
| STAT3 Pathway | 2.49E-02 | 3/73 | IGF1R,NRAS,INSR |
| TCA Cycle II (Eukaryotic) | 1.65E-02 | 2/23 | IDH3A,ACO1 |
| Thyroid Cancer Signaling | 4.62E-02 | 2/40 | NRAS,NGF |
All characterized genes within significant QTL regions were used as input in Ingenuity Pathway Analysis (IPA) software. The Top 20 significant (P ≤ 0.05) pathways are listed. The results are displayed for pathways identified when using all QTL regions (61 total QTL) which resulted in 682 (999 total) annotated genes used for pathway analysis. The bottom section of the table displays the pathways identified when using only the co-localized QTL regions (7 total co-localized QTL regions) which resulted in 185 (226 total) annotated genes used for pathway analysis. The pathways are the top canonical pathways identified by IPA and are listed in alphabetical order. The ratio refers to the number of genes that were identified in the current study compared to the total number of genes that are in the pathway according to IPA
Fig. 3Syntenic regions between chicken and swine. Syntenic regions between chicken and pig containing QTL for blood component traits. a QTL for pCO2 in both chicken and pig. Chicken QTL on GGA1 at 110–111 Mb in chicken syntenic with pig on chromosome X, 43–44 Mb. b/c GGA10 1–2 Mb in chicken and pig chromosome 7 53–60 Mb d. GGA10 16–17 Mb and swine chromosome 1, 63–226 Mb